Candida albicans is a major cause of opportunistic and life-threatening, systemic fungal infections. Hence new antifungal agents, as well as new methods to treat fungal infections, are still needed. The application of inhibitors of drug-efflux pumps may increase the susceptibility of C. albicans to drugs. We developed a new fluorescence method that allows the in vivo activity evaluation of compounds inhibiting of C. albicans transporters. We show that the potentiometric dye 3,3'-dipropylthiacarbocyanine iodide diS-C3(3) is pumped out by both Cdr1 and Cdr2 transporters. The fluorescence labeling with diS-C3(3) enables a real-time observation of the activity of C. albicans Cdr1 and Cdr2 transporters. We demonstrate that enniatin A and beauvericin show different specificities toward these transporters. Enniatin A inhibits diS-C3(3) efflux by Cdr1 while beauvericin inhibits both Cdr1p and Cdr2p.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353304PMC
http://dx.doi.org/10.3389/fmicb.2015.00176DOI Listing

Publication Analysis

Top Keywords

candida albicans
8
fungal infections
8
cdr1 cdr2
8
cdr2 transporters
8
albicans
5
transporters
5
detection inhibitors
4
inhibitors candida
4
albicans cdr
4
cdr transporters
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!